• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 13.7a: Approaches to Venous Disease, Part 1

    Steven B. Deitelzweig, MD — Ochsner Clinic Foundation

    Duration:1 hour

    Faculty Disclosure

    Disclosures not available

    Learning Objectives

    • Assess current unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), and pentasaccharide clinical evidence and guidelines in the prevention and treatment of venous thromboembolism (VTE)
    • Describe the incidence and risk of VTE
    • Review the prophylaxis of DVT